{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:24:07Z","timestamp":1793957047633,"version":"4.8.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000774","name":"The University of Newcastle","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Opinion Statement<\/jats:title>\n                  <jats:p>Cardio-oncology is a rapidly evolving subspecialty at the intersection of cancer and cardiovascular disease (CVD), two of Australia\u2019s leading causes of morbidity and mortality. Advances in cancer detection and therapy have markedly improved survival, resulting in a growing cohort of more than 1.2\u00a0million Australian cancer survivors. However, these patients are at increased risk of cardiovascular toxicity from cancer therapies, with CVD now surpassing recurrent malignancy as a leading cause of late mortality. In response, several quaternary and tertiary Australian public hospitals have established cardio-oncology services through grassroots initiatives, this has evolved into structured clinics embedded within tertiary hospitals. Despite increasing recognition and demand, access remains uneven, with services concentrated in metropolitan centres and limited provision for rural, remote, and Indigenous populations. National professional societies, including the Cardiac Society of Australia and New Zealand (CSANZ) and the Clinical Oncology Society of Australia (COSA), have recently established collaborative working groups to advance education, guidelines, and advocacy. Australia has also made significant research contributions through registries such as the Australian Cardio-Oncology Registry (ACOR) and clinical trials including SUCCOUR, BREXIT, and SMART-BREAST. Looking forward, key priorities for the Australian cardio-oncology community have surfaced including scaling workforce capacity, integrating structured education and training, expanding outreach and telehealth models, and addressing health inequities in underserved populations. These priorities along with upcoming initiatives such as the ACORES symposium will play an essential role in developing this sub speciality field. This review provides a comprehensive overview of the current cardio-oncology landscape across Australia, outlining its development, achievements, challenges, and future directions.<\/jats:p>","DOI":"10.1007\/s11864-026-01390-4","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:32:26Z","timestamp":1776508346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Current Cardio-Oncology Landscape Across Australia"],"prefix":"10.1007","volume":"27","author":[{"given":"Daniel H.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Butel-Simoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchum","family":"Bower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogda","family":"Koczwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Ell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Bennetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri R.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Ramkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doan T. M.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron L.","family":"Sverdlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"1390_CR1","unstructured":"World Health Organization, D., Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000\u20132019. 2020, Who Geneva."},{"issue":"9","key":"1390_CR2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","volume":"21","author":"NS Wilcox","year":"2024","unstructured":"Wilcox NS, et al. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nature Reviews Cardiology. 2024;21(9):617\u201331.","journal-title":"Nature Reviews Cardiology"},{"issue":"5","key":"1390_CR3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.hlc.2024.01.011","volume":"33","author":"AC Singleton","year":"2024","unstructured":"Singleton AC, et al. Integrating Cardio-Oncology Across the Research Pipeline, Policy, and Practice in Australia\u2014An Australian Cardiovascular Alliance Perspective. Heart Lung Circulation. 2024;33(5):564\u201375. ** of outstanding importance. Provides an Australian Cardiovascular Alliance perspective and a national roadmap spanning research, policy, and implementation priorities, closely aligning with the future directions discussed in this review.","journal-title":"Heart Lung Circulation"},{"issue":"3","key":"1390_CR4","first-page":"269","volume":"16","author":"T Negishi","year":"2023","unstructured":"Negishi T, et al. Cardioprotection using strain-guided management of potentially cardiotoxic cancer therapy: 3-year results of the SUCCOUR trial. Cardiovasc Imaging. 2023;16(3):269\u201378.","journal-title":"Cardiovasc Imaging"},{"issue":"41","key":"1390_CR5","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/eurheartj\/ehae574","volume":"45","author":"TH Marwick","year":"2024","unstructured":"Marwick TH, et al. Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial. European Heart Journal. 2024;45(41):4414\u201324.","journal-title":"European Heart Journal"},{"issue":"7","key":"1390_CR6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/CIRCULATIONAHA.122.062814","volume":"147","author":"SJ Foulkes","year":"2023","unstructured":"Foulkes S.J., et al. Exercise for the prevention of anthracycline-induced functional disability and cardiac dysfunction: the BREXIT study. Circulation. 2023;147(7):532\u201345. * of importance. Evaluates exercise as a preventive strategy during anthracycline therapy, supporting the role of structured lifestyle and rehabilitation interventions as part of cardio-oncology service models.","journal-title":"Circulation"},{"issue":"7","key":"1390_CR7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCULATIONAHA.122.062946","volume":"147","author":"AC Murphy","year":"2023","unstructured":"Murphy AC, et al. Randomized controlled trial of a smartphone-based intervention to enhance 6-minute walk distance during breast cancer treatment: the SMART-BREAST trial. Circulation. 2023;147(7):614\u20136.","journal-title":"Circulation"},{"key":"1390_CR8","doi-asserted-by":"crossref","first-page":"1144240","DOI":"10.3389\/fcvm.2023.1144240","volume":"10","author":"TD Williams","year":"2023","unstructured":"Williams TD, et al. Cardiovascular outcomes of cancer patients in rural Australia. Front Cardiovasc Med. 2023;10:1144240.","journal-title":"Front Cardiovasc Med"},{"key":"1390_CR9","doi-asserted-by":"crossref","first-page":"e2200361","DOI":"10.1200\/GO.22.00361","volume":"9","author":"A Diaz","year":"2023","unstructured":"Diaz A, et al. Patient information resources on cardiovascular health after cancer treatment: an audit of Australian resources. JCO global Oncol. 2023;9:e2200361.","journal-title":"JCO global Oncol"},{"key":"1390_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JGO.19.00088","volume":"6","author":"A Diaz","year":"2020","unstructured":"Diaz A, et al. Nexus of cancer and cardiovascular disease for Australia\u2019s first peoples. JCO global Oncol. 2020;6:115\u20139.","journal-title":"JCO global Oncol"},{"issue":"5","key":"1390_CR11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.hlc.2023.04.301","volume":"33","author":"AL Sverdlov","year":"2024","unstructured":"Sverdlov AL, et al. When cancer and cardiovascular disease intersect: the challenge and the opportunity of cardio-oncology. Heart Lung Circulation. 2024;33(5):558\u201363.","journal-title":"Heart Lung Circulation"},{"key":"1390_CR12","unstructured":"Health AIo, Welfare. Cancer. 2024, AIHW: Canberra."},{"key":"1390_CR13","unstructured":"Health AIo, Welfare. Heart, stroke and vascular disease: Australian facts. AIHW: Canberra; 2024."},{"issue":"11","key":"1390_CR14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","volume":"133","author":"RJ Koene","year":"2016","unstructured":"Koene RJ, et al. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104\u201314.","journal-title":"Circulation"},{"issue":"10","key":"1390_CR15","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/imj.13481","volume":"47","author":"R Conyers","year":"2017","unstructured":"Conyers R, et al. Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point? Intern Med J. 2017;47(10):1166\u201372.","journal-title":"Intern Med J"},{"issue":"3","key":"1390_CR16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/cncr.31806","volume":"125","author":"Y Ye","year":"2019","unstructured":"Ye Y, et al. Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: an Australian population-based study. Cancer. 2019;125(3):442\u201352.","journal-title":"Cancer"},{"issue":"7","key":"1390_CR17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5694\/mja2.50879","volume":"214","author":"B Koczwara","year":"2021","unstructured":"Koczwara B, et al. Late mortality in people with cancer: a population-based Australian study. Med J Aust. 2021;214(7):318\u201323.","journal-title":"Med J Aust"},{"issue":"9","key":"1390_CR18","first-page":"887","volume":"41","author":"D Cardinale","year":"1996","unstructured":"Cardinale D. A new frontier: cardio-oncology. Cardiologia (Rome Italy). 1996;41(9):887\u201391.","journal-title":"Cardiologia (Rome Italy)"},{"issue":"1","key":"1390_CR19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40959-019-0046-5","volume":"5","author":"RA Clark","year":"2019","unstructured":"Clark RA, et al. Cardiotoxicity after cancer treatment: a process map of the patient treatment journey. Cardio-Oncology. 2019;5(1):14.","journal-title":"Cardio-Oncology"},{"key":"1390_CR20","first-page":"310","volume-title":"Development of a cardio-oncology program in a community hospital","author":"DW Sundl\u00f6f","year":"2019","unstructured":"Sundl\u00f6f DW, et al. Development of a cardio-oncology program in a community hospital. Washington DC: American College of Cardiology Foundation; 2019. pp. 310\u20133."},{"issue":"1","key":"1390_CR21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40959-022-00140-3","volume":"8","author":"J White","year":"2022","unstructured":"White J, et al. Early access to a cardio-oncology clinic in an Australian context: a qualitative exploration of patient experiences. Cardio-Oncology. 2022;8(1):14.","journal-title":"Cardio-Oncology"},{"key":"1390_CR22","doi-asserted-by":"crossref","unstructured":"Yu C et al. Status of cardio-oncology in Australia in 2021: a nationwide multidisciplinary survey. Intern Med J. 2022. 52(2).","DOI":"10.1111\/imj.15682"},{"issue":"5","key":"1390_CR23","volume":"1","author":"C Toro","year":"2022","unstructured":"Toro C, et al. Cardio-oncology recommendations for pediatric oncology patients: an Australian and New Zealand Delphi consensus. JACC: Advances. 2022;1(5):100155.","journal-title":"JACC: Advances"},{"key":"1390_CR24","unstructured":"Society IC-O. Cardio-Oncology Organizations in Australia. 2025 [cited 2025 16\/09\/2025]; Available from: https:\/\/ic-os.org\/organizations\/?spec=&country=Australia"},{"key":"1390_CR25","unstructured":"Thornton-Benko E. Cardio-oncology: the GP\u2019s role. Cardiol Today. 2023. 66."},{"issue":"6","key":"1390_CR26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cardfail.2016.03.012","volume":"22","author":"DJ Lenihan","year":"2016","unstructured":"Lenihan DJ, et al. Cardio-oncology training: a proposal from the International Cardioncology Society and Canadian Cardiac Oncology Network for a new multidisciplinary specialty. J Card Fail. 2016;22(6):465\u201371.","journal-title":"J Card Fail"},{"issue":"1","key":"1390_CR27","first-page":"4","volume":"11","author":"A Fadol","year":"2025","unstructured":"Fadol A, et al. Nursing knowledge in cardio-oncology: results of an international learning needs-assessment survey. Cardio-Oncol. 2025;11(1):4-p (of importance. Defines current workforce capability gaps and training needs internationally, supporting the manuscript\u2019s education, credentialing, and multidisciplinary workforce recommendations).","journal-title":"Cardio-Oncol"},{"key":"1390_CR28","doi-asserted-by":"publisher","unstructured":"Daniels B, et al. Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study. The Lancet Regional Health. 2023. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100872.","DOI":"10.1016\/j.lanwpc.2023.100872"},{"issue":"2","key":"1390_CR29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaccao.2020.05.010","volume":"2","author":"R Untaru","year":"2020","unstructured":"Untaru R, et al. Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer. JACC CardioOncol. 2020;2(2):312\u20135.","journal-title":"JACC CardioOncol"},{"issue":"8","key":"1390_CR30","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3390\/jcm9082664","volume":"9","author":"D Ngo","year":"2020","unstructured":"Ngo D, et al. Factors associated with adverse cardiovascular events in cancer patients treated with bevacizumab. J Clin Med. 2020;9(8):2664.","journal-title":"J Clin Med"},{"key":"1390_CR31","doi-asserted-by":"publisher","unstructured":"Thavendiranathan P, Negishi T, Somerset E, Negishi K, Penicka M, Lemieux J, Aakhus S, Miyazaki S, Shirazi M, Galderisi M, Marwick TH; SUCCOUR Investigators. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy. J Am Coll Cardiol. 2021;77(4):392-401. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.020. Epub 2020 Nov 18. PMID: 33220426.","DOI":"10.1016\/j.jacc.2020.11.020"},{"key":"1390_CR32","doi-asserted-by":"publisher","unstructured":"Lapirow D, La Gerche A, Toro C, Masango E, Costello B, Porello E, Ludlow L, Marshall G, Trahair T, Mateos M, Lewin J, Byrne J, Boutros R, Manudhane R, Heath J, Ayer J, Gabriel M, Walwyn T, Saundankar J, Forsey J, Le H, Mason K, Celermajer D, Downie P, Walker R, Holland L, Martin M, McLeman L, Diamond Y, Marcocci M, Donath S, Cheung M, Elliott DA, Conyers R. The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients. Intern Med J. 2021;51(2):229-234. https:\/\/doi.org\/10.1111\/imj.14719. PMID: 31841257.","DOI":"10.1111\/imj.14719"},{"issue":"4","key":"1390_CR33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/CIRCULATIONAHA.124.070709","volume":"151","author":"HT Dillon","year":"2025","unstructured":"Dillon HT, et al. Preventing allogeneic stem cell transplant\u2013related cardiovascular dysfunction: ALLO-active trial. Circulation. 2025;151(4):292\u2013308 (** of outstanding importance. Randomised trial (ALLO-Active) showing that structured aerobic and resistance exercise during and after allogeneic stem cell transplantation preserves cardiorespiratory fitness, highlighting the value of cardio-oncology rehabilitation).","journal-title":"Circulation"},{"issue":"1","key":"1390_CR34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40959-025-00308-7","volume":"11","author":"CH Soh","year":"2025","unstructured":"Soh CH, et al. Screening for coronary artery disease among cancer survivors: rationale and design of the REDEEM-CAD study. Cardio-Oncology. 2025;11(1):10.","journal-title":"Cardio-Oncology"},{"issue":"9Supplement","key":"1390_CR35","first-page":"pPO2","volume":"84","author":"J Finney","year":"2024","unstructured":"Finney J, et al. Abstract PO2-20-06: Using the Australian Cardio-Oncology Registry to study long-term cancer therapy related cardiac dysfunction in adult oncology patients\u2013The Chris O\u2019Brien Lifehouse experience. Cancer Res. 2024;84(9Supplement):pPO2\u201320.","journal-title":"Cancer Res"},{"key":"1390_CR36","unstructured":"MCsR I. Australian cardio-oncology registry. [cited 2025 12th June]; Available from: https:\/\/www.acor-registry.org.au\/about-us\/"},{"issue":"10","key":"1390_CR37","first-page":"e009905","volume":"16","author":"AJ Teske","year":"2023","unstructured":"Teske AJ, et al. Global Cardio Oncology Registry (G-COR): registry design, primary objectives, and future perspectives of a multicenter global initiative. Circulation: Cardiovasc Qual Outcomes. 2023;16(10):e009905. of importance. Provides a contemporary registry framework that complements the rationale for national registries (e.g., ACOR) and supports harmonised data collection for outcomes, quality improvement, and research.","journal-title":"Circulation: Cardiovasc Qual Outcomes"},{"issue":"5","key":"1390_CR38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.hlc.2023.10.004","volume":"33","author":"C Yu","year":"2024","unstructured":"Yu C, et al. Rationale and design of the Cessation Of Pharmacotherapy In Recovered Chemotherapy-induced cardioToxicity (COP-RCT): a pilot study. Heart Lung Circulation. 2024;33(5):753\u20137.","journal-title":"Heart Lung Circulation"},{"key":"1390_CR39","doi-asserted-by":"publisher","unstructured":"Tan S, et al. Statins and Progression of Coronary Atherosclerosis in Melanoma Patients Treated with Immune Checkpoint Inhibitors (SOCRATES): Rationale and Design. Heart Lung and Circulation. 2023. https:\/\/doi.org\/10.1016\/j.hlc.2023.06.786.","DOI":"10.1016\/j.hlc.2023.06.786"},{"issue":"1","key":"1390_CR40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/jsre.2002.6449","volume":"105","author":"C Ko","year":"2002","unstructured":"Ko C, Chaudhry S. The need for a multidisciplinary approach to cancer care. J Surg Res. 2002;105(1):53\u20137.","journal-title":"J Surg Res"},{"key":"1390_CR41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2020.00085","volume":"10","author":"M Taberna","year":"2020","unstructured":"Taberna M, et al. The multidisciplinary team (MDT) approach and quality of care. Front Oncol. 2020;10:85.","journal-title":"Front Oncol"},{"issue":"1","key":"1390_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40959-025-00369-8","volume":"11","author":"JD Bennetts","year":"2025","unstructured":"Bennetts JD, et al. The cardio-oncology multidisciplinary team: beyond the basics. Cardio-Oncology. 2025;11(1):1\u201313. of importance. Practical overview of multidisciplinary cardio-oncology team design, including roles for nursing, pharmacy and allied health\u2014directly relevant to workforce development and service implementation.","journal-title":"Cardio-Oncology"},{"issue":"22","key":"1390_CR43","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehy453","volume":"40","author":"P Lancellotti","year":"2019","unstructured":"Lancellotti P, et al. Cardio-oncology services: rationale, organization, and implementation: a report from the ESC Cardio-Oncology council. Eur Heart J. 2019;40(22):1756\u201363.","journal-title":"Eur Heart J"},{"issue":"8","key":"1390_CR44","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.2337\/diacare.26.8.2250","volume":"26","author":"JP New","year":"2003","unstructured":"New JP, et al. Specialist Nurse-Led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT) A randomized controlled trial. Diabetes Care. 2003;26(8):2250\u20135.","journal-title":"Diabetes Care"},{"issue":"21","key":"1390_CR45","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1093\/eurheartj\/ehs071","volume":"33","author":"JM Hendriks","year":"2012","unstructured":"Hendriks JM, et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J. 2012;33(21):2692\u20139.","journal-title":"Eur Heart J"},{"issue":"19","key":"1390_CR46","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/CIRCULATIONAHA.116.020730","volume":"133","author":"S Stewart","year":"2016","unstructured":"Stewart S, et al. Impact of nurse-led, multidisciplinary home-based intervention on event-free survival across the spectrum of chronic heart disease: composite analysis of health outcomes in 1226 patients from 3 randomized trials. Circulation. 2016;133(19):1867\u201377.","journal-title":"Circulation"},{"issue":"1","key":"1390_CR47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/JCN.0000000000000224","volume":"31","author":"MH Al-Mallah","year":"2016","unstructured":"Al-Mallah MH, et al. The impact of nurse-led clinics on the mortality and morbidity of patients with cardiovascular diseases: a systematic review and meta-analysis. J Cardiovasc Nurs. 2016;31(1):89\u201395.","journal-title":"J Cardiovasc Nurs"},{"issue":"7","key":"1390_CR48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/1474515119845198","volume":"18","author":"KL Rush","year":"2019","unstructured":"Rush KL, et al. The impact of nurse-led atrial fibrillation clinics on patient and healthcare outcomes: a systematic mixed studies review. Eur J Cardiovasc Nurs. 2019;18(7):526\u201333.","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"3","key":"1390_CR49","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1188\/20.CJON.296-304","volume":"24","author":"D Kimberly Noonan","year":"2020","unstructured":"Kimberly Noonan D, et al. Oncology Nurse Practitioner Competencies. Clin J Oncol Nurs. 2020;24(3):296\u2013304.","journal-title":"Clin J Oncol Nurs"},{"issue":"3","key":"1390_CR50","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1188\/20.CJON.296-304","volume":"24","author":"LA Coombs","year":"2020","unstructured":"Coombs LA, et al. Oncology nurse practitioner competencies: Defining best practices in the oncology setting. Clin J Oncol Nurs. 2020;24(3):296.","journal-title":"Clin J Oncol Nurs"},{"issue":"4","key":"1390_CR51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.nurpra.2019.12.020","volume":"16","author":"A McCavery","year":"2020","unstructured":"McCavery A. A nurse practitioner-led model to implement and deliver unscheduled emergency cancer care. J Nurse Practitioners. 2020;16(4):271\u20135.","journal-title":"J Nurse Practitioners"},{"issue":"5","key":"1390_CR52","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1071\/AH13069","volume":"37","author":"K Cox","year":"2013","unstructured":"Cox K, et al. Nurse-led supportive care management: a 6-month review of the role of a nurse practitioner in a chemotherapy unit. Aust Health Rev. 2013;37(5):632\u20135.","journal-title":"Aust Health Rev"},{"issue":"3","key":"1390_CR53","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1200\/JOP.18.00359","volume":"15","author":"B Thom","year":"2019","unstructured":"Thom B, et al. Advanced practice providers and survivorship care: they can deliver. J Oncol Pract. 2019;15(3):e230\u20137.","journal-title":"J Oncol Pract"},{"issue":"1","key":"1390_CR54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40959-016-0014-2","volume":"2","author":"S Barros-Gomes","year":"2016","unstructured":"Barros-Gomes S, et al. Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic. Cardio-Oncology. 2016;2(1):5.","journal-title":"Cardio-Oncology"},{"key":"1390_CR55","unstructured":"Fadol A. Cardio-oncology nursing, in Practical Cardio-Oncology. CRC; 2019. pp. 189\u2013204."},{"issue":"1","key":"1390_CR56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40959-019-0041-x","volume":"5","author":"A Fadol","year":"2019","unstructured":"Fadol A, et al. A quality improvement approach to reducing hospital readmissions in patients with cancer and heart failure. Cardio-Oncology. 2019;5(1):5.","journal-title":"Cardio-Oncology"},{"issue":"19","key":"1390_CR57","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1001\/archinternmed.2009.316","volume":"169","author":"BL Carter","year":"2009","unstructured":"Carter BL, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169(19):1748\u201355.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1390_CR58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamainternmed.2014.5841","volume":"175","author":"M Viswanathan","year":"2015","unstructured":"Viswanathan M, et al. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015;175(1):76\u201387.","journal-title":"JAMA Intern Med"},{"issue":"18","key":"1390_CR59","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","volume":"320","author":"P Martin","year":"2018","unstructured":"Martin P, et al. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. JAMA. 2018;320(18):1889\u201398.","journal-title":"JAMA"},{"issue":"6","key":"1390_CR60","doi-asserted-by":"crossref","first-page":"e0253588","DOI":"10.1371\/journal.pone.0253588","volume":"16","author":"M Jaam","year":"2021","unstructured":"Jaam M, et al. Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: a systematic review and meta-analysis. PLoS One. 2021;16(6):e0253588.","journal-title":"PLoS One"},{"issue":"1","key":"1390_CR61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0897190014562382","volume":"28","author":"M Avery","year":"2015","unstructured":"Avery M, Williams F. The importance of pharmacist providing patient education in oncology. J Pharm Pract. 2015;28(1):26\u201330.","journal-title":"J Pharm Pract"},{"issue":"5","key":"1390_CR62","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jgo.2016.07.010","volume":"7","author":"M Sharma","year":"2016","unstructured":"Sharma M, et al. Polypharmacy and potentially inappropriate medication use in geriatric oncology. J geriatric Oncol. 2016;7(5):346\u201353.","journal-title":"J geriatric Oncol"},{"issue":"1","key":"1390_CR63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12885-020-06855-9","volume":"20","author":"M Ismail","year":"2020","unstructured":"Ismail M, et al. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy. BMC Cancer. 2020;20(1):335.","journal-title":"BMC Cancer"},{"issue":"15","key":"1390_CR64","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1161\/CIR.0000000000001056","volume":"145","author":"CJ Beavers","year":"2022","unstructured":"Beavers CJ, et al. Cardio-oncology drug interactions: a scientific statement from the American Heart Association. Circulation. 2022;145(15):e811-38.","journal-title":"Circulation"},{"issue":"2","key":"1390_CR65","first-page":"312","volume":"2","author":"R Untaru","year":"2020","unstructured":"Untaru R, et al. Suboptimal Use of cardioprotective medications in patients with a history of cancer. Cardio Oncol. 2020;2(2):312\u20135.","journal-title":"Cardio Oncol"},{"issue":"1","key":"1390_CR66","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1186\/s12885-016-2761-8","volume":"16","author":"E Pituskin","year":"2016","unstructured":"Pituskin E, et al. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN). BMC Cancer. 2016;16(1):733.","journal-title":"BMC Cancer"},{"key":"1390_CR67","doi-asserted-by":"crossref","first-page":"972455","DOI":"10.3389\/fcvm.2022.972455","volume":"9","author":"IF Yaseen","year":"2022","unstructured":"Yaseen IF, Farhan HA. Cardiovascular drug interventions in the cardio-oncology clinic by a cardiology pharmacist: ICOP-Pharm study. Front Cardiovasc Med. 2022;9:972455.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"1390_CR68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40959-020-00088-2","volume":"7","author":"S-A Brown","year":"2021","unstructured":"Brown S-A, et al. A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic. Cardio-oncology. 2021;7(1):2.","journal-title":"Cardio-oncology"},{"issue":"12","key":"1390_CR69","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jamacardio.2023.3558","volume":"8","author":"SG Viamonte","year":"2023","unstructured":"Viamonte SG, et al. Cardio-oncology rehabilitation for cancer survivors with high cardiovascular risk: a randomized clinical trial. JAMA cardiology. 2023;8(12):1119\u201328.","journal-title":"JAMA cardiology"},{"issue":"Supplement_2","key":"1390_CR70","doi-asserted-by":"crossref","first-page":"ii252","DOI":"10.1093\/eurheartjsupp\/suae030","volume":"26","author":"I Bisceglia","year":"2024","unstructured":"Bisceglia I, et al. Cardio-oncology rehabilitation: are we ready? Eur Heart J Suppl. 2024;26(Supplement_2):ii252\u201363.","journal-title":"Eur Heart J Suppl"},{"issue":"2","key":"1390_CR71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1741-6612.2008.00296.x","volume":"27","author":"S Davis","year":"2008","unstructured":"Davis S, Bartlett H. Healthy ageing in rural Australia: issues and challenges. Australas J Ageing. 2008;27(2):56\u201360.","journal-title":"Australas J Ageing"},{"issue":"5","key":"1390_CR72","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/1753-6405.12807","volume":"42","author":"J Jacobs","year":"2018","unstructured":"Jacobs J, et al. Regional variation in cardiovascular mortality in Australia 2009\u20132012: the impact of remoteness and socioeconomic status. Aust N Z J Public Health. 2018;42(5):467\u201373.","journal-title":"Aust N Z J Public Health"},{"key":"1390_CR73","doi-asserted-by":"crossref","unstructured":"Saleh A. Principles of telehealth and telemedicine in cardio-oncology. In: Innovations in Cardio-Oncology. Elsevier; 2025. p. 141\u201358.","DOI":"10.1016\/B978-0-443-29829-5.00027-X"},{"issue":"4","key":"1390_CR74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hlc.2016.10.013","volume":"26","author":"V Wade","year":"2017","unstructured":"Wade V, Stocks N. The use of telehealth to reduce inequalities in cardiovascular outcomes in Australia and New Zealand: a critical review. Heart Lung Circ. 2017;26(4):331\u20137.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"1390_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7954-12-1","volume":"12","author":"JR Condon","year":"2014","unstructured":"Condon JR, et al. Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality. Popul health metrics. 2014;12(1):1.","journal-title":"Popul health metrics"},{"issue":"1","key":"1390_CR76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5694\/mja16.00693","volume":"206","author":"A Brown","year":"2017","unstructured":"Brown A, Kritharides L. Overcoming cardiovascular disease in Indigenous Australians. Med J Aust. 2017;206(1):10\u20132.","journal-title":"Med J Aust"},{"issue":"1","key":"1390_CR77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1753-6405.13059","volume":"45","author":"J Cunningham","year":"2021","unstructured":"Cunningham J, Garvey G. Are there systematic barriers to participation in cancer treatment trials by Aboriginal and Torres Strait Islander cancer patients in Australia? Aust N Z J Public Health. 2021;45(1):39\u201345.","journal-title":"Aust N Z J Public Health"},{"issue":"1","key":"1390_CR78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1753-6405.13072","volume":"45","author":"W Jennings","year":"2021","unstructured":"Jennings W, et al. Rapid review of five years of Aboriginal and Torres Strait Islander health research in Australia\u2013persisting under-representation of urban populations. Aust N Z J Public Health. 2021;45(1):53\u20138.","journal-title":"Aust N Z J Public Health"},{"issue":"12","key":"1390_CR79","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11864-021-00908-2","volume":"22","author":"DA Cehic","year":"2021","unstructured":"Cehic DA, et al. The importance of primary care in cardio-oncology. Curr Treat Options Oncol. 2021;22(12):107.","journal-title":"Curr Treat Options Oncol"},{"key":"1390_CR80","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1016\/j.hlc.2023.06.785","volume":"32","author":"Q Tu","year":"2023","unstructured":"Tu Q, et al. Provision of primary care services and cardioprotective medication prescriptions in patients with cardiovascular diseases and cancer: a cross-sectional study. Heart Lung Circulation. 2023;32:S344\u20135.","journal-title":"Heart Lung Circulation"},{"key":"1390_CR81","unstructured":"Australia C. Australian Cancer Plan: Australian Government. 2021 [cited 2025 24th June]; Available from: https:\/\/www.canceraustralia.gov.au\/australian-cancer-plan\/acp"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-026-01390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-026-01390-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-026-01390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:32:39Z","timestamp":1776508359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-026-01390-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1390"],"URL":"https:\/\/doi.org\/10.1007\/s11864-026-01390-4","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}